PTPRC and neoplasm: To further explore how host MSLN expression impacts tumor burden, we analyzed omental metastases for tumor-infiltrating lymphocytes (TILs) and macrophages using a pan-b cell marker (CD45R) and pan macrophage (F4/80) marker.